- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/429 - Thiazoles condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/429
Total number of patents in this class: 744
10-year publication summary
|
44
|
41
|
44
|
48
|
33
|
38
|
32
|
40
|
35
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4754 |
14 |
| Bristol-myers Squibb Company | 4863 |
13 |
| F. Hoffmann-La Roche AG | 7942 |
13 |
| The Regents of the University of California | 19517 |
11 |
| University of Florida Research Foundation, Inc. | 3958 |
11 |
| Ambit Biosciences Corporation | 63 |
11 |
| Novartis AG | 11254 |
10 |
| Genentech, Inc. | 3869 |
9 |
| Merck Sharp & Dohme Corp. | 2219 |
9 |
| Takeda Pharmaceutical Company Limited | 2943 |
9 |
| Janssen Pharmaceutica N.V. | 3612 |
8 |
| Merck Patent GmbH | 5842 |
8 |
| Donaghys Limited | 25 |
8 |
| Alectos Therapeutics Inc. | 49 |
7 |
| Colorado State University Research Foundation | 689 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
7 |
| Janssen Sciences Ireland Unlimited Company | 435 |
7 |
| Hoffmann-La Roche Inc. | 3267 |
6 |
| Abbott Laboratories | 2464 |
6 |
| Amgen Inc. | 3899 |
6 |
| Other owners | 564 |